Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Chegg (CHGG) Q1 Loss In Line With Estimates, Sales Beat

Published 05/02/2016, 11:01 PM
Updated 07/09/2023, 06:31 AM

Chegg, Inc. (NYSE:CHGG) , a student-first connected learning platform, recently reported first quarter 2016 adjusted loss of 16 cents per share, which was in line with the Zacks Consensus Estimate.

Total net revenue of $66.7 million surpassed the Zacks Consensus Estimate of $63 million by about 6%. Total revenue declined 21% year over year. Revenues exceeded the company’s expected range of $60 million and $65 million.

Chegg Services Revenue of $25.6 million increased 14% year over year. Required Materials Revenue of $41.1 million declined 34.1% from $62.4 million in the prior year quarter.

Adjusted gross profit of $27.8 million increased 26.4% during the quarter. Adjusted gross margin of 41.6% increased significantly from 25.9% reported in the prior year quarter, owing to strong performance of Chegg Study.

Chegg announced the acquisition of Imagine Easy Solutions, a provider of online writing tools. This new addition to Chegg targets a wide range of students who need to take remedial writing courses in their freshmen year.

Second Quarter Outlook

Chegg’s expects revenue for second quarter 2016 to range between $48 million and $52 million. Adjusted EBITDA is expected to range between $5 million to $7 million in the quarter.

2016 Outlook Raised

Chegg raised its guidance for 2016, owing to its latest acquisition and positive demand trends. The company expects revenue for fiscal 2016 to range between $239 million and $257 million, higher than the prior expectation of $230 million and $250 million. Adjusted EBITDA is expected to range between $13 million to $22 million, higher than the prior expectation of $10 million to $20 million.

Chegg currently carries a Zacks Rank #2 (Buy).

Investors interested in the consumer discretionary sector can consider Box, Inc. (NYSE:BOX) , Medical Transcription Billing, Corp. (NASDAQ:MTBC) and Benefitfocus, Inc. (NASDAQ:BNFT) . While Box and Medical Transcription Billing sport a Zacks Rank #1 (Strong Buy), Benefitfocus holds a Zacks Rank #2.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


CHEGG INC (CHGG): Free Stock Analysis Report

BOX INC-A (BOX): Free Stock Analysis Report

BENEFITFOCUS (BNFT): Free Stock Analysis Report

MEDICAL TRANSCR (MTBC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.